Cosmo Pharmaceuticals Statistics
Total Valuation
SWX:COPN has a market cap or net worth of CHF 866.42 million. The enterprise value is 740.70 million.
Market Cap | 866.42M |
Enterprise Value | 740.70M |
Important Dates
The last earnings date was Thursday, March 6, 2025.
Earnings Date | Mar 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SWX:COPN has 16.02 million shares outstanding. The number of shares has increased by 1.94% in one year.
Current Share Class | n/a |
Shares Outstanding | 16.02M |
Shares Change (YoY) | +1.94% |
Shares Change (QoQ) | +3.31% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 16.01% |
Float | 8.52M |
Valuation Ratios
The trailing PE ratio is 7.11 and the forward PE ratio is 9.19.
PE Ratio | 7.11 |
Forward PE | 9.19 |
PS Ratio | 3.54 |
PB Ratio | 1.85 |
P/TBV Ratio | 2.95 |
P/FCF Ratio | 5.85 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.90, with an EV/FCF ratio of 5.00.
EV / Earnings | 5.93 |
EV / Sales | 2.96 |
EV / EBITDA | 4.90 |
EV / EBIT | 5.30 |
EV / FCF | 5.00 |
Financial Position
The company has a current ratio of 4.19, with a Debt / Equity ratio of 0.00.
Current Ratio | 4.19 |
Quick Ratio | 3.39 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.01 |
Debt / FCF | 0.01 |
Interest Coverage | 2,809.10 |
Financial Efficiency
Return on equity (ROE) is 29.31% and return on invested capital (ROIC) is 20.39%.
Return on Equity (ROE) | 29.31% |
Return on Assets (ROA) | 15.87% |
Return on Invested Capital (ROIC) | 20.39% |
Return on Capital Employed (ROCE) | 24.88% |
Revenue Per Employee | 777,307 |
Profits Per Employee | 388,193 |
Employee Count | 322 |
Asset Turnover | 0.45 |
Inventory Turnover | 3.27 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.23% in the last 52 weeks. The beta is 1.30, so SWX:COPN's price volatility has been higher than the market average.
Beta (5Y) | 1.30 |
52-Week Price Change | -21.23% |
50-Day Moving Average | 60.76 |
200-Day Moving Average | 67.82 |
Relative Strength Index (RSI) | 32.16 |
Average Volume (20 Days) | 22,776 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:COPN had revenue of CHF 250.29 million and earned 125.00 million in profits. Earnings per share was 7.61.
Revenue | 250.29M |
Gross Profit | 207.74M |
Operating Income | 139.68M |
Pretax Income | 143.88M |
Net Income | 125.00M |
EBITDA | 150.55M |
EBIT | 139.68M |
Earnings Per Share (EPS) | 7.61 |
Balance Sheet
The company has 134.12 million in cash and 2.06 million in debt, giving a net cash position of 132.06 million or 8.25 per share.
Cash & Cash Equivalents | 134.12M |
Total Debt | 2.06M |
Net Cash | 132.06M |
Net Cash Per Share | 8.25 |
Equity (Book Value) | 473.86M |
Book Value Per Share | 29.19 |
Working Capital | 144.47M |
Cash Flow
In the last 12 months, operating cash flow was 152.37 million and capital expenditures -4.27 million, giving a free cash flow of 148.10 million.
Operating Cash Flow | 152.37M |
Capital Expenditures | -4.27M |
Free Cash Flow | 148.10M |
FCF Per Share | 9.25 |
Margins
Gross margin is 83.00%, with operating and profit margins of 55.81% and 49.94%.
Gross Margin | 83.00% |
Operating Margin | 55.81% |
Pretax Margin | 57.49% |
Profit Margin | 49.94% |
EBITDA Margin | 60.15% |
EBIT Margin | 55.81% |
FCF Margin | 59.17% |
Dividends & Yields
This stock pays an annual dividend of 1.95, which amounts to a dividend yield of 3.60%.
Dividend Per Share | 1.95 |
Dividend Yield | 3.60% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | 24.09% |
Buyback Yield | -1.94% |
Shareholder Yield | 1.66% |
Earnings Yield | 14.43% |
FCF Yield | 17.09% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SWX:COPN has an Altman Z-Score of 7.21.
Altman Z-Score | 7.21 |
Piotroski F-Score | n/a |